Distinguished Faculty

Mark R. Alfenito, Ph.D., EnGen Bio, Inc.

Jeff Anderl, Ph.D., Aridis Pharmaceuticals

Anthony Baker, Merck

Norman W. Baylor, Ph.D., Biologics Consulting Group

Sue Behrens, Ph.D., Independent Consultant

Jeffrey T. Blue, M.S., Merck Research Laboratories

Liuquan (Lucy) Chang, Ph.D., Pfizer, Inc.

Pierre Chouvenc, Ph.D., Sanofi Aventis

Manon Cox, Ph.D., Protein Sciences Corporation

Alex Flood, Ph.D., PATH

Huw P. A. Hughes, Ph.D., Pfizer Animal Health

Althaf I. Hussain, Ph.D., MedImmune

Lynne A. Isopi, M.S., D.C., Merck

LaToya S. Jones Braun, Ph.D., University of Colorado

Peter Kraemer, Ph.D., Sanofi SA, Germany

Jonathan Liu, DVM, Ph.D., Medimmune

Jill Livengood, Ph.D., InViragen, Inc.

Siva Sakhamuri, Ph.D., Sanofi Pasteur Biologics

Tracy D. Scott, Pfizer, Inc.

Ian Sellick, Pall Life Sciences

Raghu Shivappa, Ph.D., Novartis Vaccines and Diagnostics

Richard O. Snyder, Ph.D., University of Florida

Indresh Srivastava, Ph.D., National Institutes of Health

Marc Thorsteinsson, Ph.D., Merck

Vadim Tsvetnitsky, Ph.D., PATH

Daniel Tusé, Ph.D., DT Consulting Group

David B. Volkin, Ph.D., University of Kansas